SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001213900-21-009004
Filing Date
2021-02-12
Accepted
2021-02-12 16:30:40
Documents
1
Group Members
VIVO CAPITAL IX, LLC.VIVO OPPORTUNITY, LLC

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO SCHEDULE 13G ea135465-13ga1vivo8_passage.htm SC 13G/A 78122
  Complete submission text file 0001213900-21-009004.txt   79697
Mailing Address 192 LYTTON AVENUE PALO ALTO CA 94301
Business Address 192 LYTTON AVENUE PALO ALTO CA 94301 650 688 0822
Vivo Capital VIII, LLC (Filed by) CIK: 0001618789 (see all company filings)

IRS No.: 471761992 | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address TWO COMMERCE SQUARE 2001 MARKET STREET, 28TH FLOOR PHILADELPHIA PA 19103
Business Address TWO COMMERCE SQUARE 2001 MARKET STREET, 28TH FLOOR PHILADELPHIA PA 19103 2678660312
Passage BIO, Inc. (Subject) CIK: 0001787297 (see all company filings)

IRS No.: 822729751 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91451 | Film No.: 21628151
SIC: 2836 Biological Products, (No Diagnostic Substances)